A+ R A-

Session 11: Novel Therapeutic approaches for WM

The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Session 11: Novel Therapeutic approaches for WM:

Session Chair: M.J. Kersten (Netherlands)

What should we expect from BCL-2 inhibitors in the management of WM? M. Davids (USA)

Do checkpoint inhibitors offer a novel therapeutic strategy in WM? S. Ansell (USA)

Could monoclonal antibodies targeting plasma cells benefit WM patients? K. Anderson (USA)

Is CAR T-cell immunotherapy appropriate for WM patients? D. Maloney (USA)

Amsterdam 2016 (IWWM-9)

Amsterdam 2016 Organizers

  • MJ Kersten MD, Ph.D (U. Amsterdam)
  • Monique Minnema MD, Ph.D (UMC Utrecht)
  • Steven Pals MD, Ph.D (U. Amsterdam)
  • Steven Treon MD, Ph.D (Dana-Farber)
  • Chris Patterson - Secretariat (Dana-Farber)

The Amsterdam 2016 Scientific Committee members:

Stephen Ansell MD, PhD (USA)
Christian Buske MD, PhD (Germany)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Xavier Leleu MD, PhD (France)
Mary McMaster MD, PhD (USA)
Giampaolo Merlini MD (Italy)
Monique Minnema MD, PhD (Netherlands)
Enrica Morra MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Linda Pilarski PhD (Canada)
Steven Treon MD PhD (USA)

Click here to download the preliminary program agenda for the 9th International Workshop on WM (IWWM-9).

Registration is closed for this event.

Amsterdam 2016 (IWWM-9) was held at the Renaissance Hotel in Amsterdam.

Renaissance Hotel Amsterdam

Please enjoy this interactive sightseeing map of Amsterdam:

Interactive Map of Amsterdam